Bristol Myers (BMY) Stock: Here’s What You Need To Know

Bristol Myers (NYSE:BMY) On August 5, 2016 Bristol Myers had a very rough day with respect to one of its targets in the pipeline.  The company’s PD-1 immune checkpoint inhibitor, known as Opdivo, failed to meet the primary endpoint of a phase 3 clinical trial. Bristol Myer’s stock did not have a good day after … Read more

Juno Therapeutics (JUNO) Stock: Here’s What You Need To Know

Juno Therapeutics (NASDAQ: JUNO) On July 12, 2016 it was announced that the FDA had released the clinical hold for the company’s lead drug candidate  JCAR015. A few weeks prior the FDA had put Juno’s trial, known as ROCKET, on a clinical hold because there were two patient deaths in the trial. The company proclaimed … Read more

Biotech Stock News (IMGN) (RGLS) (GILD) (ACHN) (OPK) (BRLI)

Immunogen (NASDAQ:IMGN) Shares of Immunogen soared as much as 68% on June 1, 2015 after the company reported positive results in patients with platinum-resistant ovarian cancer. There are about 21,290 cases of women who get ovarian cancer in the United States each year. The problem is that a lot of these patients that take chemotherapy … Read more

Biotech Stock News (SRPT) (BMRN) (PBMD) (ISR)

Sarepta Therapeutics (NASDAQ:SRPT) After the closing bell on May 19, 2015 shares of Sarepta Therapeutics were up as much as 38% in after-hours trading after the company reported that the FDA will allow the company to file a New Drug Application — NDA — for Eteplirsen. This drug Eteplirsen helps patients with Duchenne Muscular Dystrophy … Read more